Moneycontrol
Last Updated : Oct 15, 2018 04:42 PM IST | Source: PTI

Dr Reddy's to market aspirin, anti-coagulant drug in US

The aggrenox brand and the generic drug registered sales of approximately $183 million MAT (moving annual turnover) in the American market for the 12 months ending August 2018, the release added.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddys Laboratories announced it has received the approval of the US Food and Drug Administration to market aspirin and dipyridamole capsules.

Aspirin is used to treat pain, fever or inflammation while dipyridamole is used as an anti-coagulant.

They are available in 25 mg/200 mg, a press release said.

Aggrenox is a registered trademark of pharmaceutical major Boehringer Ingelheim, the release said.

The aggrenox brand and the generic drug registered sales of approximately $183 million MAT (moving annual turnover) in the American market for the 12 months ending August 2018, the release added.
First Published on Oct 15, 2018 04:32 pm
Loading...
Sections
Follow us on
Available On